Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

DCOYDecoy Therapeutics Inc.

Nasdaq · CIK 0001615219
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts333

Identity from submissions API

NameDecoy Therapeutics Inc.
CIK0001615219
TickersDCOY
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN465087339
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone346-772-0346
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Salarius Pharmaceuticals, Inc. (2019-07-23T04:00:00.000Z → 2026-01-09T05:00:00.000Z)
  • Flex Pharma, Inc. (2014-08-06T04:00:00.000Z → 2019-07-22T04:00:00.000Z)
Business address
2450 HOLCOMBE BLVD
SUITE J-608
HOUSTON
TX
77021
TX
Mailing address
2450 HOLCOMBE BLVD
SUITE J-608
HOUSTON
TX
77021
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

746 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001649553-26-000138 005-88731 261558763 34 12044
2026-11-13 S-3 S-3 0001193125-26-460860 333-300047 261553547 33 843100 1 1
2026-11-12 10-Q 10-Q 0001193125-26-458490 001-36812 261547341 34 6573096 1 1
2026-10-16 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003278 333-299353 261467403 33 1955
2026-10-16 424B3 424B3 0001193125-26-424075 333-299353 261466135 33 255029
2026-10-07 S-1 S-1 0001193125-26-417053 333-299353 261447590 33 691940 1 1
2026-09-23 8-K 8-K 1.01,3.02,7.01,9.01 0001615219-26-000019 001-36812 261401578 34 593683 1 1
2026-09-15 8-K 8-K 5.07 0001615219-26-000016 001-36812 261381588 34 181543 1 1
2026-09-02 4 4 0001193125-26-380584 5120
2026-09-02 4 4 0001229055-26-000002 5263
2026-09-02 4 4 0002079859-26-000002 5038
2026-09-02 4 4 0001329154-26-000003 5263
2026-09-02 4 4 0002079512-26-000002 5042
2026-09-02 4 4 0001233253-26-000006 5057
2026-09-02 4 4 0001457289-26-000003 5081
2026-09-02 4 4 0001769749-26-000003 5094
2026-09-02 4 4 0001634368-26-000003 5148
2026-09-02 4 4 0002148287-26-000002 4902
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003569 005-88731 261277087 34 10584
2026-08-12 10-Q 10-Q 0001193125-26-346852 001-36812 261267539 34 6784168 1 1
2026-08-04 DEF 14A DEF 14A 0001193125-26-332762 001-36812 261239860 34 883405
2026-08-04 DEFA14A DEFA14A 0001193125-26-332792 001-36812 261238630 34 837074
2026-07-31 3 3 0001193125-26-328787 15207
2026-07-24 PRE 14A PRE 14A 0001193125-26-316072 001-36812 261201546 34 883407
2026-07-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002352 333-297381 261185062 33 1955
2026-07-17 424B3 424B3 0001193125-26-307982 333-297381 261184467 33 260838
2026-07-15 8-K 8-K 5.07 0001193125-26-304949 001-36812 261178061 34 186578 1 1
2026-07-10 S-1 S-1 0001193125-26-300954 333-297381 261169005 33 649301 1 1
2026-06-29 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-26-286737 001-36812 261131142 34 20088452 1 1
2026-06-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002113 333-296773 261117513 33 1955
2026-06-15 S-1 S-1 0001193125-26-269891 333-296773 261088521 33 718627 1 1
2026-06-05 RW RW 0001193125-26-259729 333-289646 261069670 NE 10625
2026-06-04 DEFA14A DEFA14A 0001193125-26-256546 001-36812 261063290 34 18356759
2026-06-04 DEF 14A DEF 14A 0001193125-26-256541 001-36812 261063282 34 2675257 1 1
2026-05-19 8-K 8-K 5.08,8.01 0001193125-26-230749 001-36812 26998653 34 170657 1 1
2026-05-08 10-Q 10-Q 0001193125-26-214816 001-36812 26959251 34 5177732 1 1
2026-04-30 10-K/A 10-K/A 0001193125-26-195909 001-36812 26922548 34 1011433 1 1
2026-04-02 S-8 S-8 0001193125-26-140437 333-294859 26835085 33 766652 1 1
2026-04-02 8-K 8-K 8.01,9.01 0001193125-26-139145 001-36812 26830905 34 228822 1 1
2026-03-31 10-K 10-K 0001193125-26-134897 001-36812 26823222 34 9110456 1 1
2026-03-05 8-K 8-K 3.03,5.03,8.01,9.01 0001193125-26-092748 001-36812 26724450 34 245844 1 1
2026-02-25 8-K 8-K 5.07 0001193125-26-068813 001-36812 26674591 34 191927 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-26-000025 005-88731 26639897 34 11980
2026-01-09 DEF 14A DEF 14A 0001193125-26-008944 001-36812 26523880 34 863502
2026-01-08 8-K 8-K 5.03,8.01,9.01 0001615219-26-000013 001-36812 26518377 34 470803 1 1
2026-01-02 8-K 8-K 3.01 0001615219-26-000005 001-36812 26503158 34 140797 1 1
2026-01-02 4 FORM 4 0001615219-26-000004 6047
2026-01-02 8-K 8-K 5.07 0001615219-26-000003 001-36812 26503151 34 153678 1 1
2025-12-29 PRE 14A PRE 14A 0001193125-25-335395 001-36812 251609500 34 455806
2025-12-19 DEFA14A DEFA14A 0001615219-25-000198 001-36812 251588086 34 48544
2025-12-19 8-K 8-K 5.07,7.01,9.01 0001615219-25-000197 001-36812 251587977 34 166112 1 1
2025-11-24 4 FORM 4 0001615219-25-000193 5850
2025-11-24 3 FORM 3 0001615219-25-000189 400522
2025-11-24 3 FORM 3 0001615219-25-000187 400651
2025-11-24 3 FORM 3 0001615219-25-000185 403470
2025-11-20 4 FORM 4 0001615219-25-000177 5002
2025-11-19 8-K 8-K 5.02 0001615219-25-000168 001-36812 251499374 34 368504 1 1
2025-11-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000209 005-88731 251493451 34 15857
2025-11-17 8-K 8-K 7.01 0001615219-25-000166 001-36812 251492096 34 144556 1 1
2025-11-14 10-Q 10-Q 0001615219-25-000164 001-36812 251488309 34 3858432 1 1
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-111043 005-88731 251488090 34 18599
2025-11-13 8-K 8-K 1.01,2.01,3.02,3.03,5.02,5.03,8.01,9.01 0001615219-25-000162 001-36812 251478479 34 880151 1 1
2025-11-12 424B4 424B4 0001628280-25-051365 333-284368 251469494 33 1582796
2025-11-10 FWP FWP 0001615219-25-000157 333-284368 251466006 34 4490167
2025-11-07 DEFA14A DEFA14A 0001615219-25-000154 001-36812 251461978 34 350975
2025-11-07 DEF 14A DEF 14A 0001615219-25-000152 001-36812 251461963 34 1649524 1 1
2025-10-21 S-1/A S-1/A 0001628280-25-045619 333-284368 251405978 33 2264393 1 1
2025-10-21 8-K 8-K 5.02 0001615219-25-000148 001-36812 251405931 34 143359 1 1
2025-10-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004399 005-88731 251391750 34 17041
2025-10-14 8-K 8-K 8.01,9.01 0001615219-25-000145 001-36812 251389719 34 185227 1 1
2025-10-06 8-K 8-K 8.01 0001615219-25-000142 001-36812 251376986 34 148556 1 1
2025-09-26 FWP FWP 0001615219-25-000137 333-284368 251351385 34 4188368
2025-09-23 S-1/A S-1/A 0001628280-25-042500 333-284368 251334720 33 3642181 1 1
2025-09-18 8-K 8-K 1.01,3.03,9.01 0001615219-25-000135 001-36812 251321754 34 465471 1 1
2025-09-09 8-K 8-K 8.01,9.01 0001615219-25-000125 001-36812 251301710 34 186575 1 1
2025-08-27 8-K 8-K 8.01 0001615219-25-000119 001-36812 251265302 34 148462 1 1
2025-08-26 8-K 8-K 8.01,9.01 0001615219-25-000117 001-36812 251258848 34 206969 1 1
2025-08-26 8-K/A 8-K 9.01 0001615219-25-000115 001-36812 251257653 34 564509 1 1
2025-08-22 424B5 424B5 0001628280-25-041046 333-266589 251247250 33 398548
2025-08-22 8-K 8-K 8.01,9.01 0001628280-25-041043 001-36812 251247168 34 8533093 1 1
2025-08-18 8-K 8-K 5.02 0001615219-25-000107 001-36812 251226352 34 147390 1 1
2025-08-15 S-3 S-3 0001615219-25-000105 333-289646 251224845 33 761659 1 1
2025-08-15 8-K 8-K 3.03,5.03,8.01,9.01 0001615219-25-000101 001-36812 251223064 34 212988 1 1
2025-08-12 10-Q 10-Q 0001615219-25-000096 001-36812 251208112 34 3281307 1 1
2025-08-11 CORRESP filename1.htm 0001615219-25-000093 8705
2025-08-08 CORRESP filename1.htm 0001615219-25-000091 8733
2025-08-08 CORRESP filename1.htm 0001615219-25-000090 8683
2025-08-08 S-1/A S-1/A 0001628280-25-039090 333-284368 251195946 33 11285682 1 1
2025-08-07 CORRESP filename1.htm 0001615219-25-000086 62222
2025-08-06 UPLOAD filename1.pdf 0000000000-25-008287 333-284368 45804
2025-08-05 FWP FWP 0001615219-25-000082 333-284368 251184792 34 4117599
2025-07-31 8-K 8-K 2.02,3.02 0001615219-25-000080 001-36812 251172572 34 143596 1 1
2025-07-31 S-1/A S-1/A 0001628280-25-036892 333-284368 251170204 33 12235804 1 1
2025-07-29 8-K 8-K 1.01,3.03,9.01 0001615219-25-000078 001-36812 251162509 34 454670 1 1
2025-07-28 8-K 8-K 8.01 0001615219-25-000076 001-36812 251156381 34 142824 1 1
2025-07-21 8-K 8-K 1.01,3.03,9.01 0001615219-25-000072 001-36812 251135868 34 359206 1 1
2025-07-14 8-K 8-K 8.01,9.01 0001615219-25-000069 001-36812 251120214 34 187654 1 1
2025-07-08 8-K 8-K 5.07 0001615219-25-000066 001-36812 251110188 34 152596 1 1
2025-06-16 S-1/A S-1/A 0001628280-25-031631 333-284368 251050945 33 10525047 1 1
2025-06-16 8-K 8-K 8.01 0001615219-25-000064 001-36812 251050115 34 143513 1 1
2025-06-11 8-K 8-K 1.01,9.01 0001615219-25-000062 001-36812 251038849 34 319878 1 1
2025-05-27 DEFA14A DEFA14A 0001615219-25-000059 001-36812 25984799 34 1813313
2025-05-27 DEF 14A DEF 14A 0001615219-25-000057 001-36812 25984790 34 770661
2025-05-22 CORRESP filename1.htm 0001615219-25-000055 77053
2025-05-22 S-1/A S-1/A 0001628280-25-027131 333-284368 25974308 33 9883488 1 1
2025-05-15 PRE 14A PRE 14A 0001615219-25-000053 001-36812 25955814 34 770688
2025-05-15 DEF 14A DEF 14A 0001615219-25-000051 001-36812 25955162 34 770696
2025-05-14 10-Q 10-Q 0001615219-25-000048 001-36812 25946906 34 3081751 1 1
2025-05-01 UPLOAD filename1.pdf 0000000000-25-004664 333-284368 53154
2025-04-25 8-K 8-K 3.01 0001615219-25-000045 001-36812 25875083 34 157698 1 1
2025-04-17 S-1/A S-1/A 0001628280-25-018065 333-284368 25843813 33 9220455 1 1
2025-04-16 CORRESP filename1.htm 0001615219-25-000042 71973
2025-03-28 8-K 8-K 1.01,3.01,9.01 0001615219-25-000040 001-36812 25786854 34 233240 1 1
2025-03-21 10-K 10-K 0001615219-25-000037 001-36812 25760969 34 5180825 1 1
2025-03-11 8-K 8-K 8.01,9.01 0001615219-25-000033 001-36812 25725805 34 212082 1 1
2025-03-11 424B5 424B5 0001615219-25-000029 333-266589 25725695 33 426315
2025-02-19 UPLOAD filename1.pdf 0000000000-25-001886 333-284368 49967
2025-01-21 S-1 S-1 0001628280-25-001947 333-284368 25540472 33 11417363 1 1
2025-01-17 8-K 8-K 2.02,3.02 0001628280-25-001867 001-36812 25539605 34 147465 1 1
2025-01-13 424B3 424B3 0001615219-25-000007 333-283828 25524994 33 360762
2025-01-13 8-K 8-K 1.01,3.02,7.01,8.01,9.01 0001615219-25-000004 001-36812 25524921 34 21597566 1 1
2024-12-27 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-24-003936 333-283828 241586824 33 1869
2024-12-27 D xslFormDX01/primary_doc.xml 06b 0001123292-24-000416 021-533510 241586073 33 11418
2024-12-26 CORRESP filename1.htm 0001615219-24-000103 7348
2024-12-23 8-K 8-K 5.07 0001615219-24-000101 001-36812 241571739 34 165188 1 1
2024-12-18 UPLOAD filename1.pdf 0000000000-24-013994 333-283828 40282
2024-12-16 S-1 S-1 0001615219-24-000098 333-283828 241550059 33 734467
2024-12-13 8-K 8-K 1.01,3.02,9.01 0001615219-24-000092 001-36812 241546198 34 710919 1 1
2024-11-14 SC 13G/A armistice-slrx093024a1.htm 0001172661-24-005268 005-88731 241463487 34 90826
2024-11-14 10-Q 10-Q 0001615219-24-000089 001-36812 241462242 34 2853408 1 1
2024-11-01 DEFA14A DEFA14A 0001615219-24-000086 001-36812 241419922 34 346779
2024-11-01 DEF 14A DEF 14A 0001615219-24-000084 001-36812 241419908 34 825313
2024-09-27 8-K 8-K 5.08,8.01 0001615219-24-000079 001-36812 241334794 34 152833 1 1
2024-08-15 8-K 8-K 8.01 0001615219-24-000076 001-36812 241212363 34 150489 1 1
2024-08-14 8-K 8-K 8.01 0001615219-24-000073 001-36812 241207726 34 149347 1 1
2024-08-09 10-Q 10-Q 0001615219-24-000071 001-36812 241193938 34 2856280 1 1
2024-07-25 8-K 8-K 8.01,9.01 0001615219-24-000068 001-36812 241142738 34 212212 1 1
2024-07-25 424B5 424B5 0001615219-24-000066 333-266589 241142715 33 360372
2024-07-23 8-K 8-K 8.01,9.01 0001615219-24-000062 001-36812 241132432 34 212211 1 1
2024-07-22 424B5 424B5 0001615219-24-000060 333-266589 241132357 33 366085
2024-07-19 8-K 8-K 8.01 0001615219-24-000058 001-36812 241128478 34 156785 1 1
2024-07-11 8-K 8-K 8.01 0001615219-24-000055 001-36812 241111079 34 150065 1 1
2024-06-17 424B5 424B5 0001615219-24-000052 333-266589 241047003 33 31683
2024-06-17 8-K 8-K 8.01,9.01 0001615219-24-000049 001-36812 241046999 34 281887 1 1
2024-06-14 8-K 8-K 3.03,5.03,8.01,9.01 0001615219-24-000045 001-36812 241044665 34 816394 1 1
2024-05-13 10-Q 10-Q 0001615219-24-000040 001-36812 24939302 34 2617502 1 1
2024-04-22 10-K/A 10-K/A 0001615219-24-000038 001-36812 24861868 34 679777 1 1
2024-04-12 4 FORM 4 0001615219-24-000034 5297
2024-03-26 DEFA14A DEFA14A 0001615219-24-000032 001-36812 24783524 34 1029525
2024-03-26 DEF 14A DEF 14A 0001615219-24-000030 001-36812 24783483 34 599554
2024-03-22 10-K 10-K 0001615219-24-000025 001-36812 24775343 34 3998278 1 1
2024-03-20 DFAN14A FORM DFAN14A 0001062993-24-006844 001-36812 24765803 34 16845
2024-03-15 PRE 14A PRE 14A 0001615219-24-000022 001-36812 24755708 34 410409
2024-03-06 8-K 8-K 3.01 0001615219-24-000019 001-36812 24725787 34 147910 1 1
2024-02-23 8-K 8-K 5.02,8.01,9.01 0001615219-24-000017 001-36812 24666454 34 702236 1 1
2024-02-22 4 FORM 4 0001615219-24-000015 5498
2024-02-22 4 FORM 4 0001615219-24-000013 5282
2024-02-22 4 FORM 4 0001615219-24-000011 5246
2024-02-22 4 FORM 4 0001615219-24-000009 5257
2024-02-22 4 FORM 4 0001615219-24-000007 5218
2024-02-22 4 FORM 4 0001615219-24-000005 5231
2024-02-22 4 FORM 4 0001615219-24-000003 5215
2024-02-14 SC 13G armistice-slrx123123.htm 0001172661-24-001407 005-88731 24637207 34 90766
2023-11-09 10-Q 10-Q 0001615219-23-000071 001-36812 231393625 34 3161085 1 1
2023-10-27 SC 13D SCHEDULE 13D 0001099910-23-000188 005-88731 231355423 34 120034
2023-09-06 8-K 8-K 3.01 0001615219-23-000067 001-36812 231240045 34 151776 1 1
2023-08-10 8-K 8-K 2.02,9.01 0001615219-23-000063 001-36812 231159552 34 347017 1 1
2023-08-10 10-Q 10-Q 0001615219-23-000061 001-36812 231159534 34 2969936 1 1
2023-07-12 8-K 8-K 8.01,9.01 0001615219-23-000057 001-36812 231083390 34 285482 1 1
2023-06-15 8-K 8-K 5.02,5.07,9.01 0001615219-23-000055 001-36812 231015532 34 304812 1 1
2023-06-07 424B3 424B3 0001615219-23-000053 333-272249 23997649 33 215606
2023-06-06 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-06-06 17:00:00 9999999995-23-001659 333-272249 231000568 33 1820
2023-06-02 CORRESP filename1.htm 0001615219-23-000050 8457
2023-06-01 S-3/A S-3/A 0001615219-23-000047 333-272249 23985505 33 316620
2023-06-01 UPLOAD filename1.pdf 0000000000-23-005787 40353
2023-05-26 S-3 S-3 0001615219-23-000044 333-272249 23970030 33 423926
2023-05-25 D xslFormDX01/primary_doc.xml 06b 0001567619-23-006225 021-482643 23959972 33 12905
2023-05-16 8-K 8-K 1.01,3.02,8.01,9.01 0001615219-23-000042 001-36812 23928072 34 1326605 1 1
2023-05-11 10-Q 10-Q 0001615219-23-000038 001-36812 23909001 34 2895232 1 1
2023-05-01 DEFA14A DEFA14A 0001615219-23-000036 001-36812 23870130 34 296832
2023-05-01 DEF 14A DEF 14A 0001615219-23-000034 001-36812 23870108 34 1014358
2023-03-27 10-K 10-K 0001615219-23-000030 001-36812 23761576 34 4996472 1 1
2023-03-13 8-K 8-K 8.01 0001615219-23-000027 001-36812 23725885 34 167328 1 1
2023-02-15 4 FORM 4 0001615219-23-000025 4885
2023-02-15 4 FORM 4 0001615219-23-000023 6281
2023-02-15 S-8 S-8 0001615219-23-000021 333-269801 23635328 33 118424
2023-02-13 SC 13G/A AMENDMENT NO. 1 0000929638-23-000413 005-88731 23618971 34 78143
2023-01-10 8-K 8-K 8.01,9.01 0001615219-23-000017 001-36812 23520141 34 297546 1 1
2023-01-05 4 FORM 4 0001615219-23-000015 4801
2023-01-05 4 FORM 4 0001615219-23-000013 4773
2023-01-05 4 FORM 4 0001615219-23-000011 5441
2023-01-05 4 FORM 4 0001615219-23-000010 4740
2023-01-05 4 FORM 4 0001615219-23-000008 4774
2023-01-05 4 FORM 4 0001615219-23-000006 8808
2023-01-05 4 FORM 4 0001615219-23-000004 4883
2023-01-05 4 FORM 4 0001615219-23-000002 6278
2022-12-12 4/A FORM 4/A 0001615219-22-000155 6629
2022-12-12 4/A FORM 4/A 0001615219-22-000153 5233
2022-12-01 8-K 8-K 8.01,9.01 0001615219-22-000151 001-36812 221437421 34 317333 1 1
2022-11-10 10-Q 10-Q 0001615219-22-000150 001-36812 221378262 34 3297993 1 1
2022-11-10 8-K 8-K 2.02,9.01 0001615219-22-000147 001-36812 221375144 34 363139 1 1
2022-11-08 4/A FORM 4/A 0001615219-22-000144 6406
2022-11-08 4/A FORM 4/A 0001615219-22-000143 5011
2022-11-07 4 FORM 4 0001615219-22-000142 6327
2022-11-07 4 FORM 4 0001615219-22-000141 4933
2022-11-03 8-K 8-K 8.01 0001615219-22-000140 001-36812 221356522 34 240374 1 1
2022-10-27 8-K 8-K 8.01,9.01 0001615219-22-000139 001-36812 221335028 34 5063386 1 1
2022-10-18 8-K 8-K 8.01 0001615219-22-000137 001-36812 221314979 34 369031 1 1
2022-10-14 8-K 8-K 5.03,9.01 0001615219-22-000135 001-36812 221310341 34 392363 1 1
2022-08-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-08-16 16:00:00 9999999995-22-002398 333-266589 221172019 33 1820
2022-08-15 8-K 8-K 2.02,9.01 0001615219-22-000131 001-36812 221161594 34 428661 1 1
2022-08-12 CORRESP filename1.htm 0001615219-22-000129 7845
2022-08-10 UPLOAD filename1.pdf 0000000000-22-008496 40319
2022-08-05 S-3 S-3 0001615219-22-000126 333-266589 221141257 33 1149956
2022-08-05 10-Q 10-Q 0001615219-22-000124 001-36812 221140644 34 3251809 1 1
2022-08-03 8-K 8-K 8.01,9.01 0001615219-22-000117 001-36812 221133036 34 283244 1 1
2022-06-23 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-06-23 16:00:00 9999999995-22-001859 333-265535 221036858 33 1820
2022-06-21 CORRESP filename1.htm 0001615219-22-000112 7570
2022-06-21 UPLOAD filename1.pdf 0000000000-22-006658 40306
2022-06-17 8-K 8-K 5.07 0001615219-22-000110 001-36812 221024831 34 185991 1 1
2022-06-10 S-3 S-3 0001615219-22-000105 333-265535 221009698 33 311413
2022-06-08 4 FORM 4 0001615219-22-000101 4549
2022-06-08 4 FORM 4 0001615219-22-000099 4578
2022-06-07 4 FORM 4 0001615219-22-000097 8018
2022-06-06 4 FORM 4 0001615219-22-000095 4649
2022-06-06 4/A FORM 4/A 0001615219-22-000093 5017
2022-06-06 4/A FORM 4/A 0001615219-22-000091 5018
2022-06-06 4/A FORM 4/A 0001615219-22-000089 5018
2022-05-31 4 FORM 4 0001615219-22-000087 10796
2022-05-31 4 FORM 4 0001615219-22-000085 4549
2022-05-12 DEFA14A DEFA14A 0001615219-22-000083 001-36812 22918038 34 1039396
2022-05-12 8-K 8-K 2.02,9.01 0001615219-22-000081 001-36812 22917957 34 391940 1 1
2022-05-12 10-Q 10-Q 0001615219-22-000079 001-36812 22917871 34 3144182 1 1
2022-05-09 UPLOAD filename1.pdf 0000000000-22-005060 39736
2022-05-06 CORRESP filename1.htm 0001615219-22-000072 16508
2022-05-05 D xslFormDX01/primary_doc.xml 06b 0001567619-22-009611 021-444688 22896634 33 12860
2022-05-05 4 FORM 4 0001615219-22-000069 4918
2022-05-05 4 FORM 4 0001615219-22-000067 4891
2022-04-29 SC 13G sched13g.htm 0000929638-22-000846 005-88731 22876198 34 76068
2022-04-28 DEFA14A DEFA14A 0001615219-22-000065 001-36812 22866992 34 265973
2022-04-28 DEF 14A DEF 14A 0001615219-22-000063 001-36812 22866784 34 764340
2022-04-27 SC 13G SC 13G 0001104659-22-050817 005-88731 22857308 34 117713
2022-04-26 8-K 8-K 8.01,9.01 0001615219-22-000057 001-36812 22855349 34 232573 1 1
2022-04-26 424B5 424B5 0001615219-22-000052 333-231010 22850969 33 472537
2022-04-22 UPLOAD filename1.pdf 0000000000-22-004359 44172
2022-04-22 8-K 8-K 1.01,3.02,8.01,9.01 0001615219-22-000045 001-36812 22843549 34 747485 1 1
2022-04-15 PRE 14A PRE 14A 0001615219-22-000038 001-36812 22830368 34 1086025
2022-04-01 8-K 8-K 5.03,9.01 0001615219-22-000034 001-36812 22798121 34 182092 1 1
2022-03-25 10-K 10-K 0001615219-22-000028 001-36812 22772184 34 4795806 1 1
2022-03-10 8-K 8-K 2.02,9.01 0001615219-22-000022 001-36812 22729182 34 419252 1 1
2022-03-09 4 FORM 4 0001615219-22-000019 4876
2022-03-09 4 FORM 4 0001615219-22-000018 4904
2022-02-22 S-8 S-8 0001615219-22-000017 333-262896 22657986 33 192658
2022-02-10 SC 13G/A AMENDMENT NO. 1 0001214659-22-002188 005-88731 22613867 34 44710
2022-01-21 4 FORM 4 0001615219-22-000012 5198
2022-01-21 4 FORM 4 0001615219-22-000010 5226
2022-01-21 4 FORM 4 0001615219-22-000009 8537
2022-01-21 4 FORM 4 0001615219-22-000008 5402
2022-01-21 4 FORM 4 0001615219-22-000007 5199
2022-01-21 4 FORM 4 0001615219-22-000006 5165
2022-01-21 4 FORM 4 0001615219-22-000005 5165
2022-01-21 4 FORM 4 0001615219-22-000004 5376
2022-01-13 8-K 8-K 1.01,7.01,9.01 0001615219-22-000003 001-36812 22529140 34 1050312 1 1
2021-11-19 8-K 8-K 3.01 0001615219-21-000098 001-36812 211429335 34 172144 1 1
2021-11-05 4 FORM 4 0001615219-21-000096 4912
2021-11-05 4 FORM 4 0001615219-21-000095 4886
2021-11-04 10-Q 10-Q 0001615219-21-000093 001-36812 211380566 34 3510944 1 1
2021-09-16 8-K 8-K 8.01 0001193125-21-275161 001-36812 211258198 34 144023 1 1
2021-08-20 8-K 8-K 3.01 0001615219-21-000090 001-36812 211194470 34 172310 1 1
2021-08-17 4 FORM 4 0001615219-21-000087 6544
2021-08-11 4 FORM 4 0001615219-21-000085 4649
2021-08-05 8-K 8-K 2.02,9.01 0001615219-21-000084 001-36812 211148320 34 297620 1 1
2021-08-05 10-Q 10-Q 0001615219-21-000080 001-36812 211146320 34 3515870 1 1
2021-07-02 8-K 8-K 8.01,9.01 0001615219-21-000076 001-36812 211071348 34 229893 1 1
2021-07-02 424B5 424B5 0001615219-21-000075 333-231010 211071311 33 612515
2021-07-01 8-K 8-K 8.01,9.01 0001615219-21-000070 001-36812 211067013 34 329690 1 1
2021-07-01 424B5 424B5 0001615219-21-000067 333-231010 211066933 33 668886
2021-06-16 8-K 8-K 5.07 0001615219-21-000061 001-36812 211021822 34 46534
2021-05-20 8-K 8-K 8.01 0001615219-21-000054 001-36812 21942398 34 94383
2021-05-12 8-K 8-K 2.02 0001615219-21-000051 001-36812 21915025 34 137586
2021-05-12 10-Q 10-Q 0001615219-21-000049 001-36812 21914990 34 3208923 1 1
2021-05-05 4 FORM 4 0001615219-21-000042 4885
2021-05-05 4 FORM 4 0001615219-21-000040 4912
2021-04-27 DEFA14A DEFA14A 0001615219-21-000038 001-36812 21858969 34 345496
2021-04-27 DEF 14A DEF 14A 0001615219-21-000034 001-36812 21858853 34 655838
2021-03-18 10-K 10-K 0001615219-21-000026 001-36812 21755402 34 5475619 1 1
2021-03-08 8-K 8-K 1.01,9.01 0001615219-21-000022 001-36812 21722348 34 453844
2021-03-05 424B5 424B5 0001193125-21-071701 333-231010 21719722 33 632595
2021-03-03 424B5 424B5 0001193125-21-067708 333-231010 21709857 33 637403
2021-03-03 8-K 8-K 7.01,8.01,9.01 0001615219-21-000020 001-36812 21709274 34 91165
2021-02-17 8-K 8-K 8.01,9.01 0001615219-21-000017 001-36812 21644639 34 100230
2021-02-16 SC 13G c210210sc13g.htm 0001214659-21-001843 005-88731 21635312 34 52793
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-023270 005-88731 21633806 34 62684
2021-02-12 SC 13G/A AMENDMENT TO SC 13G 0001387131-21-002132 005-88731 21621773 34 131061
2021-02-05 424B5 424B5 0001193125-21-030930 333-231010 21597217 33 569771
2021-02-05 8-K 8-K 1.01 0001615219-21-000013 001-36812 21596557 34 306262
2021-02-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-02-01 16:00:00 9999999995-21-000371 333-252169 21578884 33 1819
2021-01-28 CORRESP filename1.htm 0001615219-21-000010 8804
2021-01-28 SC 13G/A SALARIUS PHARMACEUTICALS, INC. 0000902664-21-000637 005-88731 21564194 34 77464
2021-01-21 8-K 8-K 8.01 0001615219-21-000008 001-36812 21540396 34 91237
2021-01-20 UPLOAD filename1.pdf 0000000000-21-000674 40327
2021-01-15 S-3 S-3 0001615219-21-000004 333-252169 21532830 33 260404
2020-12-11 8-K/A 8-K/A 9.01 0001615219-20-000129 001-36812 201384184 34 158576
2020-12-11 8-K 8-K 1.01,3.02,3.03,9.01 0001615219-20-000126 001-36812 201382305 34 232368
2020-12-04 4 FORM 4 0001615219-20-000123 5206
2020-12-04 4 FORM 4 0001615219-20-000122 5404
2020-12-04 4 FORM 4 0001615219-20-000121 8529
2020-12-04 4 FORM 4 0001615219-20-000120 5374
2020-12-04 4 FORM 4 0001615219-20-000119 5166
2020-12-04 4 FORM 4 0001615219-20-000118 5227
2020-12-04 4 FORM 4 0001615219-20-000116 5204
2020-12-04 4 FORM 4 0001615219-20-000115 5172
2020-11-12 10-Q 10-Q 0001615219-20-000113 001-36812 201303476 34 4245888 1 1
2020-11-12 8-K 8-K 2.02 0001615219-20-000112 001-36812 201303467 34 148425
2020-11-05 4 FORM 4 0001615219-20-000106 4915
2020-11-05 4 FORM 4 0001615219-20-000104 4889
2020-10-06 8-K 8-K 3.01 0001615219-20-000102 001-36812 201227344 34 24461
2020-08-24 4 FORM 4 0001615219-20-000099 4514
2020-08-20 4 FORM 4 0001615219-20-000095 6170
2020-08-18 4 FORM 4 0001615219-20-000092 4545
2020-08-14 S-8 S-8 0001615219-20-000090 333-246310 201104936 33 115335
2020-08-12 8-K 8-K 2.02,9.01 0001615219-20-000088 001-36812 201095575 34 184963
2020-08-12 10-Q 10-Q 0001615219-20-000085 001-36812 201095464 34 4353779 1 1
2020-08-04 SC 13G p20-1462sc13g.htm 0000902664-20-002861 005-88731 201071412 34 77113
2020-08-03 8-K 8-K 1.02,8.01,9.01 0001193125-20-208095 001-36812 201069562 34 254839
2020-07-31 424B5 424B5 0001193125-20-204567 333-231010 201062515 33 669741
2020-07-29 424B5 424B5 0001193125-20-202678 333-231010 201058082 33 674265
2020-07-29 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-20-202579 001-36812 201057597 34 18948128
2020-07-16 4 FORM 4 0001615219-20-000081 15985
2020-07-16 4 FORM 4 0001615219-20-000080 5371
2020-07-16 4 FORM 4 0001615219-20-000077 5305
2020-06-22 3 FORM 3 0001615219-20-000075 13824
2020-06-19 8-K 8-K 5.07,9.01 0001615219-20-000072 001-36812 20976612 34 355253
2020-06-18 8-K 8-K 8.01 0001615219-20-000066 001-36812 20973022 34 26009
2020-05-15 10-Q/A 10-Q/A 0001615219-20-000061 001-36812 20885831 34 3805131 1 1
2020-05-14 8-K 8-K 2.02 0001615219-20-000058 001-36812 20877815 34 179562
2020-05-14 10-Q 10-Q 0001615219-20-000057 001-36812 20877606 34 626931
2020-04-29 8-K 8-K 5.02 0001615219-20-000050 001-36812 20830832 34 93401
2020-04-29 DEFA14A DEFA14A 0001615219-20-000046 001-36812 20827620 34 66620
2020-04-29 DEFA14A DEFA14A 0001615219-20-000044 001-36812 20826842 34 2495867
2020-04-29 DEF 14A DEF 14A 0001615219-20-000042 001-36812 20826804 34 5025703
2020-04-10 8-K 8-K 3.01 0001615219-20-000037 001-36812 20787196 34 21928
2020-03-27 8-K 8-K 2.02 0001615219-20-000034 001-36812 20752300 34 160420
2020-03-25 4 FORM 4 0001615219-20-000031 5291
2020-03-25 4 FORM 4 0001615219-20-000030 8630
2020-03-25 4 FORM 4 0001615219-20-000029 5275
2020-03-25 4 FORM 4 0001615219-20-000028 5292
2020-03-25 4 FORM 4 0001615219-20-000027 5351
2020-03-25 4 FORM 4 0001615219-20-000026 5258
2020-03-25 4 FORM 4 0001615219-20-000025 5373
2020-03-25 4 FORM 4 0001615219-20-000024 5258
2020-03-23 10-K 10-K 0001615219-20-000014 001-36812 20735033 34 5952753 1 1
2020-03-11 8-K 8-K 8.01 0001615219-20-000009 001-36812 20705610 34 21584
2020-02-21 SC 13D/A SC 13D/A 0001193125-20-043728 005-88731 20636538 34 32468
2020-02-21 SC 13D/A SC 13D/A 0001193125-20-043723 005-88731 20636521 34 35174
2020-02-20 4 FORM 4 0001615219-20-000005 4552
2020-02-18 4 FORM 4 0001615219-20-000003 4730
2020-02-18 SC 13G SCHEDULE 13G 0001213900-20-004074 005-88731 20623543 34 87414
2020-02-14 SC 13G d8478699_13-g.htm 0000919574-20-001614 005-88731 20618283 34 109473
2020-02-14 SC 13G SC 13G 0001104659-20-020858 005-88731 20614337 34 106233
2020-02-13 4 FORM 4 SUBMISSION 0000899243-20-004567 5592
2020-02-13 4 FORM 4 SUBMISSION 0000899243-20-004566 5553
2020-02-13 4 FORM 4 SUBMISSION 0000899243-20-004563 5541
2020-02-13 4 FORM 4 SUBMISSION 0000899243-20-004561 5590
2020-02-13 4 FORM 4 SUBMISSION 0000899243-20-004560 5525
2020-02-13 4 FORM 4 SUBMISSION 0000899243-20-004558 5555
2020-02-13 4 FORM 4 0001615219-20-000001 4553
2020-02-13 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-20-001507 005-88731 20609827 34 103154
2020-02-13 SC 13G/A slrx-13g_20191231.txt 0001037389-20-000127 005-88731 20606293 34 13412
2020-02-12 4 FORM 4 SUBMISSION 0000899243-20-004422 4634
2020-02-12 4 FORM 4 SUBMISSION 0000899243-20-004420 4599
2020-02-12 4 FORM 4 SUBMISSION 0000899243-20-004419 4585
2020-02-12 4 FORM 4 SUBMISSION 0000899243-20-004418 4569
2020-02-12 4 FORM 4 SUBMISSION 0000899243-20-004417 4599
2020-02-12 4 FORM 4 SUBMISSION 0000899243-20-004413 4637
2020-02-12 4/A FORM 4/A SUBMISSION 0000899243-20-004410 4963
2020-02-12 8-K 8-K 3.03,5.03,7.01,8.01,9.01 0001193125-20-033412 001-36812 20605388 34 443458
2020-02-10 424B4 424B4 0001193125-20-028933 333-235879 20589235 33 672334
2020-02-07 S-1MEF S-1MEF 0001193125-20-027299 333-236306 20584464 33 59142
2020-02-06 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-02-06 17:00:00 9999999995-20-000274 333-235879 20584412 33 1819
2020-02-06 S-1/A S-1/A 0001193125-20-025727 333-235879 20580681 33 1095781
2020-02-05 CORRESP filename1.htm 0001193125-20-025417 5560
2020-02-05 CORRESP filename1.htm 0001193125-20-025393 7139
2020-01-29 FWP FWP 0001193125-20-017741 333-235879 20556502 34 23958753
2020-01-28 S-1/A S-1/A 0001193125-20-016222 333-235879 20551704 33 1186293
2020-01-14 UPLOAD filename1.pdf 0000000000-20-000340 46106
2020-01-10 S-1 S-1 0001193125-20-005401 333-235879 20521163 33 3224375 1
2019-11-26 4 FORM 4 0001615219-19-000055 4537
2019-11-12 10-Q 10-Q 0001615219-19-000054 001-36812 191210024 34 5162850 1 1
2019-10-28 424B5 424B5 0001193125-19-275560 333-231010 191171203 33 552563
2019-10-28 8-K 8-K 1.01,7.01,9.01 0001193125-19-275531 001-36812 191171173 34 256546
2019-10-22 8-K 8-K 5.07 0001615219-19-000051 001-36812 191161935 34 42248
2019-09-18 DEF 14A DEF 14A 0001615219-19-000048 001-36812 191100321 34 4510335
2019-09-18 8-K/A 8-K/A 8.01,9.01 0001615219-19-000047 001-36812 191100271 34 2221554
2019-09-16 8-K 8-K 5.02,8.01,9.01 0001615219-19-000043 001-36812 191095266 34 2432989
2019-09-13 4/A FORM 4/A 0001615219-19-000041 5506
2019-09-13 3/A FORM 3/A 0001615219-19-000040 8895
2019-09-13 4 FORM 4 0001615219-19-000039 5415
2019-09-13 4 FORM 4 0001615219-19-000038 5202
2019-09-13 4 FORM 4 0001615219-19-000037 5214

Latest XBRL company facts

One latest value per concept from companyfacts (333 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 2.39M 2026-11-11 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
dei EntityPublicFloat Entity Public Float USD 1.90M 2025-06-30 2025 FY 10-K/A 2026-04-30 0001193125-26-195909
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 124,511 2025-01-01 2025-12-31 DEF 14A 2026-06-04 0001193125-26-256541
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 225,059 2025-01-01 2025-12-31 DEF 14A 2026-06-04 0001193125-26-256541
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 798,678 2025-01-01 2025-12-31 DEF 14A 2026-06-04 0001193125-26-256541
ecd PeoTotalCompAmt PeoTotalCompAmt USD 900,266 2025-01-01 2025-12-31 DEF 14A 2026-06-04 0001193125-26-256541
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 0.35 2025-01-01 2025-12-31 DEF 14A 2026-06-04 0001193125-26-256541
ffd NetFeeAmt NetFeeAmt USD 0 2026-11-13 S-3 2026-11-13 0001193125-26-460860
ffd TtlFeeAmt TtlFeeAmt USD 4,350 2026-11-13 S-3 2026-11-13 0001193125-26-460860
ffd TtlOfferingAmt TtlOfferingAmt USD 50.00M 2026-11-13 S-3 2026-11-13 0001193125-26-460860
ffd TtlOffsetAmt TtlOffsetAmt USD 4,350 2026-11-13 S-3 2026-11-13 0001193125-26-460860
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-13 S-3 2026-11-13 0001193125-26-460860
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 778,612 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 28,278 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap AccruedMarketingCostsCurrent Accrued Marketing Costs, Current USD 10,481 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 171,474 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 3,000 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 801,095 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 106.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD 99,758 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 212,547 2019-04-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 8.00M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-07 0001615219-18-000018
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 396,407 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0001615219-22-000028
us-gaap AdvertisingExpense Advertising Expense USD 18,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 53,512 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001615219-20-000014
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap AssetAcquisitionConsiderationTransferred AssetAcquisitionConsiderationTransferred USD 6.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable USD 4.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap AssetAcquisitionConsiderationTransferredTransactionCost AssetAcquisitionConsiderationTransferredTransactionCost USD 1.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap Assets Assets USD 8.79M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap AssetsCurrent Assets, Current USD 8.38M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 38 2017-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1,285 2017-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 14.13M 2017-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 2.00M 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 93 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 0 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 2.00M 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value USD 0 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 0 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 0 2014-02-26 2014-12-31 2015 Q2 10-Q 2015-08-05 0001615219-15-000039
us-gaap AvailableForSaleSecuritiesGrossRealizedGains Available-for-sale Securities, Gross Realized Gains USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001615219-18-000018
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGainLoss1 Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) USD 0 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-05 0001615219-15-000039
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions security 0 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap BusinessAcquisitionProFormaEarningsPerShareBasic Business Acquisition, Pro Forma Earnings Per Share, Basic USD/shares 0.5 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -7.35M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 5.23M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 11.67M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 2.97M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 141,818 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable USD 1.06M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue USD 3.23M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 5.09M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 6.59M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt USD 139,823 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other USD 8,846 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets USD 43,286 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001615219-22-000028
us-gaap Cash Cash USD 12.96M 2018-09-30 2018 Q3 10-Q 2018-11-05 0001615219-18-000061
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 1.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 8.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 23.95M 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 8.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -2.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD -3.23M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001615219-18-000018
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 3,450 2025-09-30 2025 Q3 10-Q 2025-11-14 0001615219-25-000164
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 1 2019-07-18 2021 FY 10-K 2022-03-25 0001615219-22-000028
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 142,711 2021-07-01 2022 Q2 10-Q 2022-08-05 0001615219-22-000124
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 5.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 2.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 2.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap CommonStockValue Common Stock, Value, Issued USD 238 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -3.62M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2021-03-31 2021 Q1 10-Q 2021-05-12 0001615219-21-000049
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001615219-20-000014
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 6.97M 2015-02-03 2017 FY 10-K 2018-03-07 0001615219-18-000018
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 401,126 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 83,477 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 83,934 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 40,217 2018-01-01 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 900,000 2020-07-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.025 2020-07-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap DebtInstrumentIssuedPrincipal DebtInstrumentIssuedPrincipal USD 577,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 8.19M 2017-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions security 6 2017-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap DebtSecuritiesAvailableForSaleRealizedGain Debt Securities, Available-for-sale, Realized Gain USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions security 0 2017-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 0 2015-12-31 2015 FY 10-K 2016-03-08 0001615219-16-000118
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 5,000 2019-12-31 2019 FY 10-K 2020-03-23 0001615219-20-000014
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 0 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap DeferredRevenue Deferred Revenue USD 2.69M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 881,229 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 21.79M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 4.14M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 21.79M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 0 2015-12-31 2015 FY 10-K 2016-03-08 0001615219-16-000118
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 11.96M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 50,688 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 2.28M 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 3.94M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 462,785 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 394,900 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 336,229 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 21.79M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-08 0001615219-16-000118
us-gaap DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs USD 5,174 2019-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals USD 0 2017-12-31 2017 FY 10-K 2018-03-07 0001615219-18-000018
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2017-12-31 2017 FY 10-K 2018-03-07 0001615219-18-000018
us-gaap Depreciation Depreciation USD 46,506 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 44,419 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 8,710 2022-03-31 2022 Q1 10-Q 2022-05-12 0001615219-22-000079
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2019-12-31 2019 FY 10-K 2020-03-23 0001615219-20-000014
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 4,429 2019-09-30 2019 Q3 10-Q 2019-11-12 0001615219-19-000054
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -11.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.31 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001615219-22-000028
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -11.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.001 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.028 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001615219-22-000028
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 48,797 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 31,383 2019-12-31 2019 FY 10-K 2020-03-23 0001615219-20-000014
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 500,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -6,540 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001615219-20-000014
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -23,617 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 4.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap Goodwill Goodwill USD 0 2022-12-31 2022 FY 10-K 2023-03-27 0001615219-23-000030
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-22 0001615219-24-000025
us-gaap GrantsReceivable Grants Receivable USD 1.60M 2021-12-31 2021 FY 10-K 2022-03-25 0001615219-22-000028
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-22 0001615219-24-000025
us-gaap GrantsReceivableNoncurrent Grants Receivable, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-27 0001615219-23-000030
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -2.22M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214816
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -7.98M 2016-10-01 2016-12-31 2016 FY 10-K 2017-03-08 0001615219-17-000021
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -0.5 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -11.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -11.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001615219-20-000113
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001615219-20-000014
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001615219-19-000054
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2014-12-31 2014 FY 10-K 2015-03-24 0001615219-15-000004
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 2.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -2.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 25,826 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 23,675 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001615219-20-000014
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -96 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -27,915 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -200,385 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap IncreaseDecreaseInAccruedInvestmentIncomeReceivable Increase (Decrease) in Accrued Investment Income Receivable USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001615219-19-000054
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -323,967 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001615219-22-000028
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -535,060 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD -21,728 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-12 0001615219-19-000054
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001615219-20-000113
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0001615219-25-000037
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 200,960 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD 1.83M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-12 0001615219-20-000085
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001615219-18-000018
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 114,009 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap InterestIncomeOperating Interest Income, Operating USD 26,574 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap InventoryNet Inventory, Net USD 130,920 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 7,247 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 123,673 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap InventoryWriteDown Inventory Write-down USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 2,454 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-03 0001615219-17-000032
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001615219-21-000093
us-gaap Liabilities Liabilities USD 4.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 8.79M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap LiabilitiesCurrent Liabilities, Current USD 4.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 0 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 0 2016-12-31 2016 FY 10-K 2017-03-08 0001615219-17-000021
us-gaap MinorityInterestOwnershipPercentageByNoncontrollingOwners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners pure 0.02 2011-12-31 2019 Q3 10-Q 2019-11-12 0001615219-19-000054
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 5.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -121,790 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -8.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -7.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -5.58M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0001615219-25-000037
us-gaap NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic USD -2.22M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-214816
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap NumberOfCountriesInWhichEntityOperates Number of Countries in which Entity Operates Segment 1 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap NumberOfReportingUnits Number of Reporting Units numberOfReportableUn 1 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001615219-19-000054
us-gaap OperatingExpenses Operating Expenses USD 8.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -7.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2,350 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 466,593 2017-12-31 2017 FY 10-K 2018-03-07 0001615219-18-000018
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 168,793 2014-12-31 2014 FY 10-K 2015-03-24 0001615219-15-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 311,062 2017-12-31 2017 FY 10-K 2018-03-07 0001615219-18-000018
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 351,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 50,000 2017-06-30 2017 Q2 10-Q 2017-08-02 0001615219-17-000067
us-gaap OtherAssetsCurrent Other Assets, Current USD 209,173 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 27,670 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 23,040 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-08 0001615219-17-000021
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 367 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001615219-18-000018
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 2,306 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2016-12-31 2016 FY 10-K 2017-03-08 0001615219-17-000021
us-gaap OtherNoncashExpense Other Noncash Expense USD 20,310 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001615219-22-000028
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 200,000 2025-09-30 2025 Q3 10-Q 2025-11-14 0001615219-25-000164
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 8.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap OtherSalesRevenueNet Other Revenue, Net (Deprecated 2018-01-31) USD 2,327 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001615219-20-000014
us-gaap PaymentsForRestructuring Payments for Restructuring USD 57,365 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap PaymentsOfDividends Payments of Dividends USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 10,617 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 8.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-22 0001615219-24-000025
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 200,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001615219-25-000164
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 577,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001615219-22-000028
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001615219-20-000014
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 1,674 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 1,674 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 212,313 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap PrepaidInsurance Prepaid Insurance USD 3,140 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 138,412 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 2.87M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-05 0001615219-15-000039
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 9.87M 2020-01-01 2020-03-31 2020 Q1 10-Q/A 2020-05-15 0001615219-20-000061
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 5.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 2.96M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 28,422 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 875,555 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 385,118 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 1.60M 2022-09-30 2022 Q3 10-Q 2022-11-10 0001615219-22-000150
us-gaap RelatedPartyDepositLiabilities Related Party Deposit Liabilities USD 139,823 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 3.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 8.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001615219-23-000038
us-gaap RestrictedCash Restricted Cash USD 126,595 2018-09-30 2018 Q3 10-Q 2018-11-05 0001615219-18-000061
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 0 2019-12-31 2019 FY 10-K 2020-03-23 0001615219-20-000014
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 0 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap RestrictedCashAndInvestmentsCurrent Restricted Cash and Investments, Current USD 2.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap RestructuringCharges Restructuring Charges USD 1.76M 2018-06-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap RestructuringReserve Restructuring Reserve USD 0 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 0 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -102.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001615219-23-000038
us-gaap Revenues Revenues USD 535,059 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap RoyaltyExpense Royalty Expense USD 17,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap SalesDiscountsGoods Sales Discounts, Goods (Deprecated 2018-01-31) USD 8,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 176,255 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 178,582 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 672,695 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.347 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.233 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.82 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.046 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.046 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2023-09-30 2023 Q3 10-Q 2023-11-09 0001615219-23-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 16,391 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 351.9 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 349,974 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 15,004 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.95 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2023-09-30 2023 Q3 10-Q 2023-11-09 0001615219-23-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 28,727 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 231.08 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 2.30M 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 4.1 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 40,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap SharesHeldInEmployeeStockOptionPlanCommittedToBeReleased Shares Held in Employee Stock Option Plan, Committed-to-be-Released shares 713,996 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap ShippingHandlingAndTransportationCosts Shipping, Handling and Transportation Costs (Deprecated 2018-01-31) USD 25,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-02 0001615219-18-000032
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 4.55M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.067 2025-08-15 2025 Q3 10-Q 2025-11-14 0001615219-25-000164
us-gaap StockIssued1 Stock Issued USD 4.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 722,568 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-18 0001615219-21-000026
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 355,676 2018-10-01 2018-10-31 2019 FY 10-K 2020-03-23 0001615219-20-000014
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001615219-19-000008
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001615219-18-000018
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 9,712 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-27 0001615219-23-000030
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 4.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0001615219-22-000028
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 28,548 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001615219-24-000025
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 2.61M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2019-04-01 2019-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 253,474 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 63,097 2018-04-01 2018-06-30 2019 Q2 10-Q 2019-07-17 0001615219-19-000024
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 4.69M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134897
us-gaap WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001615219-22-000028
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 280,183 2022-04-30 2023 FY 10-K 2024-03-22 0001615219-24-000025
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 637,221 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 30.55M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001615219-21-000049
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 637,221 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458490

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →